» Articles » PMID: 23664897

Colorectal Cancer in Inflammatory Bowel Disease: Results of the 3rd ECCO Pathogenesis Scientific Workshop (I)

Abstract

Epidemiological studies demonstrate an increased risk of colorectal cancer in patients with inflammatory bowel disease (IBD). A detailed literature review was conducted on epidemiology, risk factors, pathophysiology, chemoprevention and outcomes of colorectal cancer (CRC) in IBD as part of the 3rd ECCO scientific pathogenesis workshop.

Citing Articles

Optimal cutpoint of preoperative neutrophil-lymphocyte ratio and associated postoperative prognosis in colorectal cancer patients.

Chiu T, Liu T, Chang C, Hu W Int J Colorectal Dis. 2025; 40(1):55.

PMID: 40009243 PMC: 11865130. DOI: 10.1007/s00384-025-04839-4.


Unraveling Crucial Mitochondria-Related Genes in the Transition from Ulcerative Colitis to Colorectal Cancer.

Wang F, Xie L, Tang Y, Deng T Drug Des Devel Ther. 2024; 18:3175-3189.

PMID: 39071816 PMC: 11283795. DOI: 10.2147/DDDT.S455098.


Gut microbiota and their derivatives in the progression of colorectal cancer: Mechanisms of action, genome and epigenome contributions.

Ahmad A, Mahmood N, Raza M, Mushtaq Z, Saeed F, Afzaal M Heliyon. 2024; 10(8):e29495.

PMID: 38655310 PMC: 11035079. DOI: 10.1016/j.heliyon.2024.e29495.


Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota.

Zhang H, Shi Y, Lin C, He C, Wang S, Li Q Front Immunol. 2024; 14:1338918.

PMID: 38288125 PMC: 10822953. DOI: 10.3389/fimmu.2023.1338918.


Differential Gene Expression of Checkpoint Markers and Cancer Markers in Mouse Models of Spontaneous Chronic Colitis.

Ephraim R, Fraser S, Devereaux J, Stavely R, Feehan J, Eri R Cancers (Basel). 2023; 15(19).

PMID: 37835487 PMC: 10571700. DOI: 10.3390/cancers15194793.